COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Cambridge Oncology Seminar Series > ‘Multi-dimensional cancer-immune cell interaction during metastasis’
‘Multi-dimensional cancer-immune cell interaction during metastasis’Add to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Mala Jayasundera. Host: Sakari Vanharanta (SV358@MRC-CU.cam.ac.uk) The co-evolution between cancer and the immune system during metastasis is dynamic and versatile. In syngeneic mammary tumor models, we discovered unexpected functions of type I T helper cells and NK cells in shaping the metastasis process. The former prevents metastasis by promoting vessel normalization, a process involving improved pericyte attachment to endothelium, increased blood perfusion, decreased vessel permeability, and consequently mitigated hypoxia. The latter exerts selective pressures for CTC -clustering and polyclonal metastasis seeding, by eliminating single cell CTCs that have presumably lost epithelial traits. Therapies augmenting T cell and NK cell functions efficiently restrict metastases, although resistance often develops through multiple mechanisms including accumulation of myeloid-derived suppressor cells. Our research uncovered spatiotemporally specific interactions between cancer cells and various immune cells, and cries for in-depth investigations on collective activities of multiple cell types beyond cytotoxic T cells. This talk is part of the Cambridge Oncology Seminar Series series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsThe Smuts Memorial Fund Lecture CCIMI Biological Anthropology Easter Term Seminars 2012Other talksStatistics Clinic Lent 2019 - Easter Vacation Blockchain & crypto: A legal view How to make good scientific figures Cambridge Global Food Security Symposium 2019: Generating Practical Solutions for India and Africa Selective inhibition of phosphatases to boost protein quality control : A possible treatment for degenerative diseases |